Venn Life Sciences Holdings PLC (LON:VENN – Get Free Report)’s share price passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 6.85 ($0.09) and traded as low as GBX 6.70 ($0.09). Venn Life Sciences shares last traded at GBX 6.85 ($0.09), with a volume of 1,027,544 shares changing hands.
Venn Life Sciences Stock Up 7.0 %
The firm has a market cap of £4.89 million and a P/E ratio of -2.14. The firm’s 50-day moving average price is GBX 6.85 and its 200 day moving average price is GBX 6.85. The company has a debt-to-equity ratio of 35.83, a current ratio of 2.30 and a quick ratio of 1.48.
About Venn Life Sciences
Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling.
Featured Articles
- Five stocks we like better than Venn Life Sciences
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- The Average 401k Balance by Age Explained
- Why is the Ex-Dividend Date Significant to Investors?
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- How to Calculate Inflation Rate
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Venn Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venn Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.